NextGenNK Director Hans-Gustaf Ljunggren presented on NK cell-based immunotherapies during the inauguration of the Karolinska ATMP Center on August 25, 2025, sharing experiences from past and upcoming clinical studies.
NextGenNK took part in the inauguration of the Karolinska ATMP Center on August 25, 2025. Representing the competence center, Director Hans-Gustaf Ljunggren delivered a presentation on NK cell-based immunotherapies against human cancer and beyond.
He shared insights from his long-standing experience in the NK cell-therapy field, briefly presenting examples of clinical studies he has led in the past as well as upcoming studies from the Malmberg and Alici laboratories.
Hans-Gustaf's contribution highlighted advancing innovative NK cell-based therapies and fostering collaboration within the ATMP community.
